Ricevi le ultime notizie sulle azioni Sinopharm Gr Co con aggiornamenti su tendenze di mercato, dati finanziari e analisi di Benzinga. Rimani informato sulle performance di SHTDY

Ultime notizie per

SINOPHARM GRP CO UNSP/ADR by Sinopharm Group Co. Ltd.

Sinopharm Group Co Ltd

Sinopharm Gr Co

Sinopharm Gr Co (SHTDY) Previsione

Notizie

Vendite allo scoperto

Commerci governativi

Rapporto azionario

Founded in 2003, Sinopharm is the largest wholesaler and retailer of drugs and medical devices in China and listed on the Hong Kong Stock Exchange in 2009. It is a core subsidiary of China National Pharmaceutical Group. Sinopharm's largest operating segment is pharmaceutical distribution, making up over 70% of its total revenue by the end of 2024. In 2018, Sinopharm acquired the largest Chinese medical device distributor, China National Scientific Instruments and Materials. Now, medical device distribution accounts for over 20% of Sinopharm's total revenue. Sinopharm's downstream customers range from hospitals and other health services institutions to end-customers.

Comments

Sinopharm Gr Co Notizie sulle azioni

Notizie

Ultime notizie per

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO